Software to evaluate clinical, epidemiological data and chest computed tomography to predict which patients with COVID-19 will develop a severe form of the disease.

Not Applicable

Recruiting

• Conditions: Coronavirus infection, unspecified. Shock, unspecified. Septicaemia, unspecified. Adult respiratory distress syndrome. Acute renal failure; B34.2; R57.9; A41.9

• Registration Number: RBR-7dsxsv
• Lead Sponsor: Diagnósticos da América Sociedade Anônima (DASA)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-04
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Signs and symptoms of acute respiratory syndrome. Positive epidemiological history for COVID-19, which may include recent contact (last 14 days) with a confirmed or suspected case, recent trip (last 14 days) to a high-incidence location, or presentation of symptoms after the start of the community transmission phase of SARS-CoV-2 (after 20/03/2020) when the date of hospitalization. Have performed, when symptomatic, a chest computed tomography.

Exclusion Criteria

Presence of neoplastic (primary or metastatic) lung lesions, manifested as nodules, masses, consolidations, septal thickening (lymphatic carcinomatosis) or pleural thickening. Chest computed tomography with the presence of movement, acquisition or reconstruction artifacts that make it impossible to apply the segmentation algorithms. Computed tomography exams with low quality pulmonary segmentation, or cut slice thickness greater than 3.0 mm.

Study & Design

• Study Type: Observational
• Study Design: Not specified